Treating Low-Income Smokers in the Hospital Emergency Department
2 other identifiers
interventional
780
1 country
1
Brief Summary
This study will test the effectiveness of an Emergency Department (ED) initiated tobacco intervention which includes counseling and medication. Our proposed intervention combines a Brief Negotiated Interview (BNI) with initiation of nicotine patch and gum in the ED, as well as a faxed referral to the state's Smokers' Quitline. A 6 week supply of nicotine patches and nicotine gum are provided to subjects in the intervention arm. Subjects randomized to the control arm will receive a brochure from the state's Smokers' Quitline only. The primary hypothesis is that the intervention will be superior to the control condition in reducing self-reported and biochemically verified 7-day tobacco abstinence at 3 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2010
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 30, 2011
CompletedFirst Posted
Study publicly available on registry
April 4, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2014
CompletedResults Posted
Study results publicly available
August 4, 2014
CompletedAugust 4, 2014
July 1, 2014
2.5 years
March 30, 2011
July 8, 2014
July 8, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Biochemical Verification of Tobacco Abstinence
Biochemical verification means a breathalyzer reading for carbon monoxide.
3 months after enrollment
Self-report of Tobacco Abstinence or Reduction
Questionnaires to assess self reported tobacco abstinence
3 months
Secondary Outcomes (5)
Self-reported Tobacco Reduction or Abstinence
1 month post enrollment
Health Care Service Utilization
1 month post enrollment
Self-reported Tobacco Reduction or Abstinence
12 months post enrollment
Health Care Service Utilization
3 months post enrollment
Health Care Service Utilization
12 months post enrollment
Study Arms (2)
Standard Care
NO INTERVENTIONSubjects receive a brochure for the state's Smokers' Quitline only.
SBIRT+NRT
EXPERIMENTALSubjects receive a 6 week course of NRT, a motivational Brief Negotiated Interview, and a facilitated referral to the state's Smokers' Quitline.
Interventions
Brief Negotiated Interview is a manual-guided therapy designed for the ED setting. The purpose is to assist subjects to change some aspect of their smoking and to decide to start nicotine replacement therapy while in the ED. It combines techniques from motivational interviewing and stages of change. a 6-week supply of nicotine replacement therapy is given in the form of patches and gum and subjects are encouraged to use both concurrently. Patches come in 21 mg, 14 mg, and 7 mg doses and the dosage is determined based on how many cigarettes per day a subject is smoking. All subjects receive 400 pieces of 2 mg nicotine gum. All subjects complete a referral form for the state's Smokers' Quitline which is then faxed directly to the Quitline's vendor.
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- Speaks English
- Willing and able to give informed consent
- \>100 cigarettes lifetime
- Current daily or some day smoker
- Smokes \> 5 cigarettes/day
- Medicaid or self-pay insurance
You may not qualify if:
- Too ill or unable to consent
- Not interested in study participation
- Not interested in quitting
- Pregnant, nursing, or trying to conceive
- Current use of tobacco cessation products (patch, gum, inhaler, nasal spray, lozenge, e-cigarette)
- Actively psychotic or mentally ill
- Leaving ED against medical advice
- Investigator discretion
- Lives outside of New Haven County
- Does not have phone with CT area code
- In police custody
- History of allergic reaction to nicotine replacement products
- Currently receiving formal tobacco dependence tx
- Currently taking Zyban, Wellbutrin (bupropion) or Chantix(varenicline)
- Resides in an extended care facility
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yale Universitylead
- National Cancer Institute (NCI)collaborator
- National Institutes of Health (NIH)collaborator
Study Sites (1)
Yale University
New Haven, Connecticut, 06510, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Steven L. Bernstein, MD
- Organization
- Yale University
Study Officials
- PRINCIPAL INVESTIGATOR
Steven L. Bernstein, MD
Yale University
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 30, 2011
First Posted
April 4, 2011
Study Start
October 1, 2010
Primary Completion
April 1, 2013
Study Completion
January 1, 2014
Last Updated
August 4, 2014
Results First Posted
August 4, 2014
Record last verified: 2014-07